BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Campo G, Pavasini R, Malagù M, Mascetti S, Biscaglia S, Ceconi C, Papi A, Contoli M. Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management. Cardiovasc Drugs Ther 2015;29:147-57. [PMID: 25645653 DOI: 10.1007/s10557-014-6569-y] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Tudorache E, Fira-Mladinescu O, Traila D, Marc M, Rajnoveanu RM, Tofolean DE, Fildan AP. Endothelial dysfunction: The possible link between cardiovascular comorbidities and phenomenon of inflammaging from COPD. Medicine (Baltimore) 2022;101:e30078. [PMID: 35984178 DOI: 10.1097/MD.0000000000030078] [Reference Citation Analysis]
2 Bauldoff GS, Carlin BW. Pulmonary comorbidities in cardiac rehabilitation. Progress in Cardiovascular Diseases 2022. [DOI: 10.1016/j.pcad.2022.01.009] [Reference Citation Analysis]
3 Zarrabian B, Mirsaeidi M. A Trend Analysis of Chronic Obstructive Pulmonary Disease Mortality in the United States by Race and Sex. Ann Am Thorac Soc 2021;18:1138-46. [PMID: 33347376 DOI: 10.1513/AnnalsATS.202007-822OC] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Ge H, Liu X, Gu W, Feng X, Zhang F, Han F, Qian Y, Jin X, Gao B, Yu L, Bao H, Zhou M, Li S, Jie Z, Wang J, Chen Z, Hang J, Zhang J, Zhu H. Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP. J Inflamm Res 2021;14:3335-48. [PMID: 34290518 DOI: 10.2147/JIR.S315600] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Draghici A, Buzea CA, Delcea C, Vijan A, Dan GA. Predictors associated with increased troponin in acute decompensated and chronic heart failure patients. Revista Romana de Medicina de Laborator 2021;29:153-64. [DOI: 10.2478/rrlm-2021-0015] [Reference Citation Analysis]
6 Piroli F, Leone AM, Calcagno S. The role of chronic obstructive pulmonary disease in acute coronary syndrome patients: a critical risk factor for lipid plaque burden? Minerva Cardiol Angiol 2021;69:735-7. [PMID: 33427427 DOI: 10.23736/S2724-5683.20.05555-3] [Reference Citation Analysis]
7 Ferrari R, Pavasini R, Campo G. Beta-blockers and COPD: how can harmony be restored in a marriage in crisis? Eur Heart J 2020;41:4423-4. [PMID: 33316038 DOI: 10.1093/eurheartj/ehaa873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ruggiero R, Scoccia A, Serenelli M, Erriquez A, Passarini G, Tebaldi M, Brugaletta S, Madden S, Bernucci D, Pavasini R, Cimaglia P, Maietti E, Campo G, Biscaglia S. Lipid plaque burden in NSTE-ACS patients with or without COPD: insights from the SCAP Trial. Minerva Cardiol Angiol 2021;69:738-45. [PMID: 33258568 DOI: 10.23736/S2724-5683.20.05424-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Shnoda M, Gajjar K, Ivanova V. COPD and Cardiovascular Disease: A Review of Association, Interrelationship, and Basic Principles for Integrated Management. Crit Care Nurs Q 2021;44:91-102. [PMID: 33234862 DOI: 10.1097/CNQ.0000000000000342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Rodriguez Lozano P, Bourque JM. Beyond traditional cardiovascular risk factors: Could frailty and other morbidities explain the worse prognosis in patients undergoing pharmacologic stress? J Nucl Cardiol 2020. [PMID: 33241477 DOI: 10.1007/s12350-020-02441-5] [Reference Citation Analysis]
11 Rogliani P, Ritondo BL, Laitano R, Chetta A, Calzetta L. Advances in understanding of mechanisms related to increased cardiovascular risk in COPD. Expert Rev Respir Med 2021;15:59-70. [PMID: 33084434 DOI: 10.1080/17476348.2021.1840982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Huang X, Redfors B, Chen S, Liu Y, Ben-Yehuda O, Puskas JD, Kandzari DE, Merkely B, Horkay F, van Boven AJ, Boonstra PW, Sabik JF, Serruys PW, Kappetein AP, Stone GW. Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial. Eur J Cardiothorac Surg 2019;55:1144-51. [PMID: 30596978 DOI: 10.1093/ejcts/ezy438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Yu X, Zhu GP, Cai TF, Zheng JY. Establishment of risk prediction model and risk score for in-hospital mortality in patients with AECOPD. Clin Respir J 2020;14:1090-8. [PMID: 32757441 DOI: 10.1111/crj.13246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Aisanov Z, Khaltaev N. Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients. J Thorac Dis 2020;12:2791-802. [PMID: 32642187 DOI: 10.21037/jtd.2020.03.60] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Recio Iglesias J, Díez-Manglano J, López García F, Díaz Peromingo JA, Almagro P, Varela Aguilar JM. Management of the COPD Patient with Comorbidities: An Experts Recommendation Document. Int J Chron Obstruct Pulmon Dis 2020;15:1015-37. [PMID: 32440113 DOI: 10.2147/COPD.S242009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
16 Wang M, Lin EP, Huang LC, Li CY, Shyr Y, Lai CH. Mortality of Cardiovascular Events in Patients With COPD and Preceding Hospitalization for Acute Exacerbation. Chest 2020;158:973-85. [PMID: 32184108 DOI: 10.1016/j.chest.2020.02.046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
17 Almagro P, De la Sierra A, Acosta E, Navarro A, Garcia ME, Valdivieso S, Castañeda T, Agustí A. Spirometrically Confirmed Chronic Obstructive Pulmonary Disease Worsens Long-Term Prognosis after Percutaneous Coronary Intervention. Am J Respir Crit Care Med 2018;197:824-6. [PMID: 28885856 DOI: 10.1164/rccm.201707-1389LE] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
18 Schiopu SRI, Zacherl M, Todica A, Bartenstein P, Milger K, Leuschner G, Munker D, Bauer M, Massberg S, Behr J, Neurohr C, Huber BC, Kneidinger N. Feasibility and accuracy of SPECT myocardial perfusion imaging in end-stage lung disease. J Nucl Cardiol 2020;27:903-11. [PMID: 31428982 DOI: 10.1007/s12350-019-01851-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Liao KM, Kuo LT, Lu HY. Increased risk of peripheral arterial occlusive diseases in patients with chronic obstructive pulmonary disease: a nationwide study in Taiwan. Int J Chron Obstruct Pulmon Dis 2019;14:1455-64. [PMID: 31308650 DOI: 10.2147/COPD.S202029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Almagro P, Acosta E, Navarro A, Murillo M, Valdivielso S, de la Sierra A. Study of arterial stiffness in patients with an acute coronary event and chronic obstructive pulmonary disease confirmed by spirometry. Revista Clínica Española (English Edition) 2019;219:251-5. [DOI: 10.1016/j.rceng.2019.01.007] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Ayatollahi H, Gholamhosseini L, Salehi M. Predicting coronary artery disease: a comparison between two data mining algorithms. BMC Public Health 2019;19:448. [PMID: 31035958 DOI: 10.1186/s12889-019-6721-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 8.3] [Reference Citation Analysis]
22 Lim S, Choo EH, Kim CJ, Choi IJ, Lee KY, Hwang B, Lee J, Chung WS, Chang K. Ticagrelor Does Not Improve Endothelial Dysfunction in Stable Survivors of Acute Coronary Syndrome. J Cardiovasc Pharmacol Ther 2019;24:442-9. [DOI: 10.1177/1074248419841640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
23 Biscaglia S, Ruggiero R, Di Cesare A, Serenelli M, Ferrari R. Angina and chronic obstructive pulmonary disease: facing the perfect storm. Eur Heart J Suppl 2019;21:C17-20. [PMID: 30996702 DOI: 10.1093/eurheartj/suz042] [Reference Citation Analysis]
24 Hong Y, Graham MM, Southern D, McMurtry MS. The Association between Chronic Obstructive Pulmonary Disease and Coronary Artery Disease in Patients Undergoing Coronary Angiography. COPD 2019;16:66-71. [PMID: 30897970 DOI: 10.1080/15412555.2019.1566894] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Chen H, Yang R, Tang Y, Fu X. Effects of curcumin on artery blood gas index of rats with pulmonary fibrosis caused by paraquat poisoning and the expression of Smad 4, Smurf 2, interleukin-4 and interferon-γ. Exp Ther Med 2019;17:3664-70. [PMID: 30988750 DOI: 10.3892/etm.2019.7341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
26 Almagro P, Acosta E, Navarro A, Murillo MF, Valdivielso S, de la Sierra A. Study of arterial stiffness in patients with an acute coronary event and chronic obstructive pulmonary disease confirmed by spirometry. Rev Clin Esp (Barc) 2019;219:251-5. [PMID: 30660321 DOI: 10.1016/j.rce.2018.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Lin WC, Chen CW, Lu CL, Lai WW, Huang MH, Tsai LM, Li CY, Lai CH. The association between recent hospitalized COPD exacerbations and adverse outcomes after percutaneous coronary intervention: a nationwide cohort study. Int J Chron Obstruct Pulmon Dis 2019;14:169-79. [PMID: 30655664 DOI: 10.2147/COPD.S187345] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
28 Petta V, Perlikos F, Loukides S, Bakakos P, Chalkias A, Iacovidou N, Xanthos T, Tsekoura D, Hillas G. Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease. Heart Fail Rev 2017;22:753-63. [PMID: 28840400 DOI: 10.1007/s10741-017-9646-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 Muñoz-Esquerre M, Ferreiro JL, Huertas D, Marcano AL, López-Sánchez M, Roura G, Gómez-Hospital JA, Dorca J, Cequier A, Santos S. Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis 2018;13:141-8. [PMID: 29343953 DOI: 10.2147/COPD.S152660] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
30 Rogliani P, Brusasco V, Fabbri L, Ungar A, Muscianisi E, Barisone I, Corsini A, De Angelis G. Multidimensional approach for the proper management of a complex chronic patient with chronic obstructive pulmonary disease. Expert Rev Respir Med 2018;12:103-12. [PMID: 29241393 DOI: 10.1080/17476348.2018.1417041] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Bhatt SP. Hidden in Plain Sight: Lung Impairment in Ischemic Heart Disease. Am J Respir Crit Care Med 2016;194:528-30. [PMID: 27585376 DOI: 10.1164/rccm.201607-1521ED] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
32 Backman R, Weber P, Turner AM, Lee M, Litchfield I. Assessing the extent of drug interactions among patients with multimorbidity in primary and secondary care in the West Midlands (UK): a study protocol for the Mixed Methods Multimorbidity Study (MiMMS). BMJ Open 2017;7:e016713. [PMID: 28928183 DOI: 10.1136/bmjopen-2017-016713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
33 Li Y, Yang S, Chen S, Guo X, Chen Y. Patients with symptoms and characteristics consistent with obstructive sleep apnea are at a higher risk for acute and subacute stent thrombosis after percutaneous coronary stent implantation: a single-center case-control study. BMC Cardiovasc Disord 2017;17:226. [PMID: 28821224 DOI: 10.1186/s12872-017-0658-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
34 Contoli M, Campo G, Pavasini R, Marchi I, Pauletti A, Balla C, Spanevello A, Ferrari R, Papi A. Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients. Eur J Intern Med 2018;47:82-6. [PMID: 28821412 DOI: 10.1016/j.ejim.2017.08.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
35 Cheyne WS, Williams AM, Harper MI, Eves ND. Acute volume loading exacerbates direct ventricular interaction in a model of COPD. J Appl Physiol (1985) 2017;123:1110-7. [PMID: 28729396 DOI: 10.1152/japplphysiol.01109.2016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
36 Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agustí A. Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care. Am J Respir Crit Care Med 2016;194:1319-36. [PMID: 27589227 DOI: 10.1164/rccm.201604-0690SO] [Cited by in Crossref: 97] [Cited by in F6Publishing: 110] [Article Influence: 19.4] [Reference Citation Analysis]
37 Malerba M, Nardin M, Radaeli A, Montuschi P, Carpagnano GE, Clini E. The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients. Expert Rev Hematol 2017;10:821-32. [PMID: 28693343 DOI: 10.1080/17474086.2017.1353416] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
38 Cazzola M, Calzetta L, Rinaldi B, Page C, Rosano G, Rogliani P, Matera MG. Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases. Drugs 2017;77:721-32. [DOI: 10.1007/s40265-017-0731-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
39 Campo G, Vieceli Dalla Sega F, Pavasini R, Aquila G, Gallo F, Fortini F, Tonet E, Cimaglia P, Del Franco A, Pestelli G, Pecoraro A, Contoli M, Balla C, Biscaglia S, Rizzo P, Ferrari R. Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease. Thromb Haemost 2017;117:1208-16. [PMID: 28331925 DOI: 10.1160/TH16-12-0973] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
40 Krisai P, Haschke M, Buser PT, Mueller C. Ticagrelor induced systemic inflammatory response syndrome. BMC Cardiovasc Disord 2017;17:14. [PMID: 28056791 DOI: 10.1186/s12872-016-0443-8] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
41 Pavasini R, Tavazzi G, Biscaglia S, Guerra F, Pecoraro A, Zaraket F, Gallo F, Spitaleri G, Contoli M, Ferrari R, Campo G. Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis. Chron Respir Dis 2017;14:117-26. [PMID: 27956645 DOI: 10.1177/1479972316674393] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
42 Lin SH, Perng DW, Chen CP, Chai WH, Yeh CS, Kor CT, Cheng SL, Chen JJ, Lin CH. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease. Int J Chron Obstruct Pulmon Dis 2016;11:3051-8. [PMID: 27980402 DOI: 10.2147/COPD.S115137] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
43 Neukamm A, Einvik G, Didrik Høiseth A, Søyseth V, Henrik Holmedahl N, Kononova N, Omland T. The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients. BMC Pulm Med 2016;16:164. [PMID: 27887619 DOI: 10.1186/s12890-016-0319-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
44 Ucar FM. A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio. BMC Cardiovasc Disord 2016;16:186. [PMID: 27716070 DOI: 10.1186/s12872-016-0367-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
45 Yuan X, Zhou G, He Y, Feng A. A minor but deadly surgery of colonic polypectomy in an elderly and fragile patient: a case report and the review of literature. World J Surg Oncol 2016;14:252. [PMID: 27669818 DOI: 10.1186/s12957-016-1010-6] [Reference Citation Analysis]
46 Bundhun PK, Yanamala CM, Huang F. Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studies. BMC Cardiovasc Disord 2016;16:161. [PMID: 27577530 DOI: 10.1186/s12872-016-0343-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
47 Jeong SH, Lee H, Carriere KC, Shin SH, Moon SM, Jeong BH, Koh WJ, Park HY. Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients. Int J Chron Obstruct Pulmon Dis 2016;11:1857-65. [PMID: 27536097 DOI: 10.2147/COPD.S103063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
48 Campo G, Pavasini R, Barbetta C, Maietti E, Mascetti S, Biscaglia S, Zaraket F, Spitaleri G, Gallo F, Tonet E, Papi A, Ferrari R, Contoli M. Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history. Int J Cardiol 2016;222:806-12. [PMID: 27522379 DOI: 10.1016/j.ijcard.2016.08.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
49 Booij HG, Damman K, Warnica JW, Rouleau JL, van Gilst WH, Westenbrink BD. β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial. Cardiovasc Drugs Ther 2015;29:277-85. [PMID: 26071975 DOI: 10.1007/s10557-015-6600-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
50 Chang R, Lin J, Kuo W, Hsieh DJ, Yeh Y, Shen C, Day C, Ho T, Viswanadha VP, Huang C. Angiotensin-(1-7) attenuated long-term hypoxia-stimulated cardiomyocyte apoptosis by inhibiting HIF-1 α nuclear translocation via Mas receptor regulation. Growth Factors 2016;34:11-8. [DOI: 10.3109/08977194.2016.1155150] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
51 van Dijk CE, Garcia-Aymerich J, Carsin AE, Smit LA, Borlée F, Heederik DJ, Donker GA, Yzermans CJ, Zock JP. Risk of exacerbations in COPD and asthma patients living in the neighbourhood of livestock farms: Observational study using longitudinal data. Int J Hyg Environ Health 2016;219:278-87. [PMID: 26831047 DOI: 10.1016/j.ijheh.2016.01.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
52 Pavasini R, Biscaglia S, d'Ascenzo F, Del Franco A, Contoli M, Zaraket F, Guerra F, Ferrari R, Campo G. Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis. COPD 2016;13:509-14. [PMID: 26678708 DOI: 10.3109/15412555.2015.1099620] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
53 Nilsson U, Johansson B, Eriksson B, Blomberg A, Lundbäck B, Lindberg A. Ischemic heart disease among subjects with and without chronic obstructive pulmonary disease--ECG-findings in a population-based cohort study. BMC Pulm Med 2015;15:156. [PMID: 26637314 DOI: 10.1186/s12890-015-0149-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
54 Chang RL, Lin JW, Hsieh DJ, Yeh YL, Shen CY, Day CH, Ho TJ, Viswanadha VP, Kuo WW, Huang CY. Long-term hypoxia exposure enhanced IGFBP-3 protein synthesis and secretion resulting in cell apoptosis in H9c2 myocardial cells. Growth Factors 2015;33:275-81. [PMID: 26340107 DOI: 10.3109/08977194.2015.1077824] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
55 Sathiyakumar V, Avilucea FR, Whiting PS, Jahangir AA, Mir HR, Obremskey WT, Sethi MK. Risk factors for adverse cardiac events in hip fracture patients: an analysis of NSQIP data. International Orthopaedics (SICOT) 2016;40:439-45. [DOI: 10.1007/s00264-015-2832-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
56 Huber MB, Wacker ME, Vogelmeier CF, Leidl R. Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review. PLoS One 2015;10:e0132670. [PMID: 26168154 DOI: 10.1371/journal.pone.0132670] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
57 Amalakuhan B, Adams SG. Improving outcomes in chronic obstructive pulmonary disease: the role of the interprofessional approach. Int J Chron Obstruct Pulmon Dis 2015;10:1225-32. [PMID: 26170651 DOI: 10.2147/COPD.S71450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
58 Pavasini R, d'Ascenzo F, Campo G, Biscaglia S, Ferri A, Contoli M, Papi A, Ceconi C, Ferrari R. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis. Int J Cardiol 2015;191:187-93. [PMID: 25965630 DOI: 10.1016/j.ijcard.2015.05.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]